Autolus Limited Company
Autolus is a leader in T-cell programming and manufacturing technology.
Funding Status:
IPO
Headquarters:
United Kingdom
Founded Date:
2014
Employee Number:
11-50
Industry:
Genomic and Epigenominc Instabillity
Technology:
Cell Therapies
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A